davemn Posted - 1 week ago

$KRMD 11/14 KRMD Analyst Updates: Lake Street - Buy $4.00 B. Riley - Buy $4.00 Craig-Hallum - Buy $5.00 Piper Sandler - Buy $3.50 Canaccord - Buy $4.00

davemn Posted - 1 week ago

$KRMD Another awesome quarter from the Koru team and I am not surprised at all. Looking forward to 2025 as it should be an inflection point in this stock price. A little speculation but if the MC holds up we will be going back on the Russell next spring which will be a nice boost leading up. Also it looks like Topline Capital has bought 4.6M shares this year, and very recently added 1.8M - a nice endorsement!

prismmarketview Posted - 1 week ago

$KRMD https://prismmarketview.com/koru-medical-systems-delivers-third-straight-quarter-of-double-digit-growth-raises-2024-outlook-amid-strong-q3-results/

PenkeTrading Posted - 1 week ago

I found you an Overbought RSI (Relative Strength Index) on the daily chart of Repro Med Systems Inc. Is that bullish or bearish? $KRMD #RsiOverbought #NASDAQ

GoGreen21 Posted - 1 week ago

$KRMD Very nice earnings call and forward guidance. 2000 shares in my retirement account. Slow and steady wins the race.

Gesundheit Posted - 1 week ago

$KRMD Could someone please help investawaymillions and short this to 2.00? He missed the boat and would desperately like to get on board.

investawaymillions Posted - 10/28/24

background of some investors in $KRMD Allegations FAILURE TO PROPERLY SUPERVISE SENIOR EQUITY TRADERS AND NOTIFY COMPLIANCE IN CONNECTION WITH MARKET MAKING ACTIVITIES AND JUNIOR SYNDICATE STAFF IN CONNECTION WITH SALESFORCE COMMUNICATIONS RELATED TO A STABILIZATION AND DISTRIBUTION OF EQUITY SECURITIES. Broker Comment I VOLUNTARILY RESIGNED FROM MY POSITION AS HEAD OF SYNDICATE AT DEUTSCHE BANK IN LONDON DURING AN INVESTIGATION INTO ACTIONS OF SR. EQUITY TRADERS AND SYNDICATE COMMUNICATIONS RELATING TO TRANSACTION IN SHARES OF CYTOS BIOTECH AND SCANIA AB. I FULLY COOPERATED WITH THE UK FSA IN THESE INVESTIGATIONS. THE FINAL RESULT WAS THAT BOTH DEUTSCHE BANK AND THE HEAD OF EQUITY TRADING WERE CENSURED AND FINED FOR THEIR ACTIONS.

copywrites Posted - 1 month ago

$KRMD Houston we have ZERO Volume 👀 crazy, never seen before 🫣

copywrites Posted - 2 months ago

$KRMD Houston we have Volume 👀

_www_larval_com_ Posted - 2 months ago

$KRMD has turned 3% higher to -4% (~1Mv) moments ago, 09/20 options, follow for more volatility.

Gesundheit Posted - 2 months ago

$KRMD I see what you did there :). Grabbed 500 more.

GoGreen21 Posted - 2 months ago

$KRMD Just me and one or two other guys in this.

davemn Posted - 08/22/24

$KRMD On track to double their revenue in FY26, $0 debt, high margins. Its the golden goose -> highly profitable growth stock with a razor/razorblade model and chronic patient base. This will be HUGE, just have patience.

Gesundheit Posted - 3 months ago

$KRMD I think from what I can tell on this board I am their only retail holder. I am quietly buying a massive amount. Been working on it for two years now.

davemn Posted - 3 months ago

$KRMD CSL Behring 13 August 2024 "HIZENTRA® (Immune Globulin Subcutaneous (Human), 20% Liquid) sales were up 19% driven by increasing patient diagnosis rates and the launch of the 50mL pre-filled syringe. HIZENTRA® continues to be the clear market leader for subcutaneous immunoglobulin. Underlying demand for Ig continues to be strong due to significant patient needs in core indications – namely Primary Immune Deficiency, Secondary Immune Deficiency and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)."

Himel92 Posted - 3 months ago

The Last month Performance for $KRMD Opening Price: $2.50 Closing Price: $2.13 Highest Price: $2.72 Lowest Price: $2.13 Percentage Change: -14.80% Data analyst: AITX

Stock_Titan Posted - 3 months ago

$KRMD KORU Medical Systems, Inc. Announces 2024 Q2 Financial Results, a Record Quarter With 22% Revenue Growth; Raises Full Year 2024 Guidance https://www.stocktitan.net/news/KRMD/koru-medical-systems-inc-announces-2024-q2-financial-results-a-kv91r9tylu67.html

davemn Posted - 3 months ago

$KRMD Sticking with my post from a few months ago... we'll see! "price follows the revenue growth very closely. Should be a good Q1 earnings and further out comps in 24, leading to an impressive 2025 - 25+% growth rate. Given that they execute: 2024 5X EV/sales ~$4 2025 10X EV/sales ~$9 Lots of $$ on the sidelines waiting for rate cuts .. Small cap GROWTH stock that is PROFITABLE & ZERO debt!"

NVDAMillionaire Posted - 07/31/24

$KRMD KORU Medical Systems, Inc. (NASDAQ:KRMD) Q1 2024 Performance Analysis http://beyondspx.com/2024/07/31/koru-medical-systems-inc-nasdaqkrmd-q1-2024-performance-analysis/

Stock_Titan Posted - 4 months ago

$KRMD KORU Medical Systems to Report Second Quarter 2024 Financial Results on August 7, 2024 https://www.stocktitan.net/news/KRMD/koru-medical-systems-to-report-second-quarter-2024-financial-results-1dt0tbgelp77.html

OpenOutcrier Posted - 4 months ago

RECAP 7/2 +Pos Comments: $AGCO + CFRA $KRMD + Canaccord $BUR + Jefferies RECAP 7/2 -Neg Comments: $RNAC - Oppenheimer Live Breaking trading news www.openoutcrier.com

GoGreen21 Posted - 4 months ago

$KRMD Trend Analysis KRMD appears to be in a strong bullish trend. Its 200-day moving average is upwards sloping and the MACD histogram is above 0. Comparative Relative Strength analysis shows that this issue is outperforming the S&P 500.

Stock_Titan Posted - 4 months ago

$KRMD KORU Medical Systems Receives Regulatory Clearance for FreedomEdge® Infusion System in Japan https://www.stocktitan.net/news/KRMD/koru-medical-systems-receives-regulatory-clearance-for-freedom-edge-a7sw2xvw5v0d.html

NVDAMillionaire Posted - 06/30/24

$KRMD KORU Medical Systems, Inc. (NASDAQ:KRMD) – Delivering Innovative Solutions for Large Volume Subcutaneous Infusion http://beyondspx.com/2024/06/30/koru-medical-systems-inc-nasdaqkrmd-delivering-innovative-solutions-for-large-volume-subcutaneous-infusion/

GoGreen21 Posted - 06/27/24

$KRMD KRMD a well kept secret.

_www_larval_com_ Posted - 06/24/24

$GRI -7%[-2%] $REVB -7%[23%] $TBLT -4%[24%] $KRMD -4%[7%] $WENA -3%[-27%] most notable movement into the final minutes of trading.

davemn Posted - 5 months ago

$KRMD didn’t think this would breakout until after the Russell shuffle but I’ll take it! Just the beginning. Koru Medical is a multi billion $$ company in a few years.

GoGreen21 Posted - 5 months ago

$KRMD Loading more on every dip.

Stock_Titan Posted - 5 months ago

$KRMD Simplifying Subcutaneous Drug Administration: SCHOTT Pharma and KORU Medical Systems Announce Collaboration to Advance Large Volume Subcutaneous Infusion https://www.stocktitan.net/news/KRMD/simplifying-subcutaneous-drug-administration-schott-pharma-and-koru-gub2g6af9ejn.html

DonCorleone77 Posted - 5 months ago

$KRMD Koru Medical announces new feasibility study Koru Medical Systems announced a collaboration with a global pharmaceutical company to initiate a feasibility study with Koru Medical's Freedom Infusion System for an FDA and EMA approved subcutaneous oncology biologic drug, that is currently being delivered via a manual syringe administration by a healthcare professional. The Freedom System is a purely mechanical ambulatory drug delivery device with 11 drugs approved on the label and over 40,000 patients globally. The system is designed to deliver large volumes of biologic medications from 2mL to over 100mL subcutaneously. The Freedom System is capable of allowing patients to self-administer their therapy at home and/or by healthcare professionals in a clinic setting. Conversion of IV biologics to subcutaneous administration formulations is a growing trend in the oncology market. Evidence suggests subcutaneous administration of oncology therapy simplifies treatment, reduces pressure on hospitals, and improves patients' quality of life. With the development of new subcutaneous drug therapies, there is an opportunity to develop drug delivery administration solutions which will optimize drug administration for healthcare providers and patients. "This collaboration presents an exciting, new opportunity to enter the growing oncology subcutaneous biologic market to solve significant unmet needs in the delivery of this life-saving therapy with our patient-centric solutions," said Linda Tharby, KORU Medical's President and CEO. Linda Tharby went on to say, "There are multiple subcutaneous oncology biologics currently approved using manual administration with an estimate of over one million global infusions. Upon successful completion of the feasibility study, we anticipate progressing to commercialization of the Freedom System for this drug within the following 12 months."